期刊文献+

吉西他滨联合奥沙利铂治疗老年晚期非小细胞肺癌临床观察 被引量:7

下载PDF
导出
摘要 肺癌是当今常见的恶性肿瘤之一,其中非小细胞肺癌占80%以上,而非小细胞肺癌患者一半左右为65岁以上的老年人。我国老年肺癌发病率已经超过世界男性平均水平。老年患者确诊时大多为晚期,失去手术机会。化疗是治疗晚期非小细胞肺癌重要手段,过去我们常用单药化疗治疗老年患者,不良反应虽然小,但疗效也受影响。
出处 《实用癌症杂志》 2011年第6期655-656,共2页 The Practical Journal of Cancer
  • 相关文献

参考文献3

  • 1Ferlay J, Autier P, Boniol M, et al. Estimates of cancer incidence and mortality in Europe in 2006 [ J ]. Ann 0ncol,2007,18:581.
  • 2李田,于力克,陈文萍.异长春花碱单药化疗高龄晚期非小细胞肺癌[J].中国癌症杂志,2001,11(6):525-527. 被引量:2
  • 3Franciosi V, Barhieri R, Aitini E, et al. Gemcitahine and oxaliplatin : a safe and active regimen in poor prognosis advanced non-small cell lung cancer patients[ J]. Lung Cancer,2003,41 ( 1 ) :101.

二级参考文献7

  • 1Feliu J, Lopez Gomez L, Madronal C, et al.Gemcitabine plus vinorelbine in nonsmall cell lung carcinoma patients age 70 years or old or patients who cannot receive cisplatin.Oncopaz Cooperative Group[J].Cancer,1999,86(8):1463-1469.
  • 2Wozniak AJ.Single-agent vinorelbine in the treatment of non-small cell lung cancer[J].Semin Oncol,1999,26(5 Suppl 16):62-66;discussion 71-72.
  • 3Frasci G, Lorusso V, Panza N,et al.Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer[J]. J Clin Oncol,2000,18(13):2529-2536.
  • 4Ricci S,Antonuzzo A,Galli L,et al. Gemcitabine monotherapy in elderly patients with advanced non-small cell lung cancer: a multicenter phase Ⅱstudy[J]. Lung Cancer,2000,27(2):75-80.
  • 5Lilenbaum RC,Langenberg P,Dickersin K. Single agent versus combination chemotherapy in patients with advanced nonsmall cell lung carcinoma:a meta-analysis of response, toxicity, and survival[L]. Cancer,1998,82(1):116-126.
  • 6Stewart DJ, Goel R, Gertler SZ, et al.Concurrent use of multiple low dose chemotherapy agents with differing mechanisms of action as a strategy vs passive resistance: A pilot study[J]. Int J Oncol,1999,15(4):693-699.
  • 7Hainsworth JD,Burris HA, Litchy S, et al. Weekly docetaxel in the treatment of elderly patients with advaned nonsmall cell lung carcinoma. A Minnie Pearl Cancer Research Network Phase ⅡTrial[J]. Cancer,2000,89(2):328-333.

同被引文献66

  • 1徐成伟,陈威龙.顺铂时辰化疗在晚期NSCLC治疗中的应用价值[J].实用癌症杂志,2014,29(2):162-164. 被引量:7
  • 2邓颖,胡洪林,杨兰,潘海霞,朱学强.培美曲塞或吉西他滨联合顺铂治疗晚期肺腺癌的对照研究[J].实用癌症杂志,2014,29(3):330-332. 被引量:7
  • 3孙清,华军,王琦,徐伟,毛永杰.吉西他滨加或不加顺铂治疗老年人晚期非小细胞肺癌的随机对照研究[J].中华老年医学杂志,2006,25(5):354-355. 被引量:7
  • 4孙燕,石远凯.床肿瘤内科学手册[M].5版,北京:人民卫生出版社,2007:152-153.
  • 5孙燕,石远凯床肿瘤内科学手册(M].5版,北京人民卫生出版社,2007:388.
  • 6Laskin JJ,Sandler AB. First-line treatment for advanced non-small-cell lung cancer[J]. Oncology(Williston Park),2005,19(13) :1671- 1676.
  • 7Gridelli C. Does chemotherapy have a role as palliative therapy for unfit or elderly patients with nonsmall cell lung cancer[ J ]. Lung Cancer,2002,38 ( suppl 2 ) :45-50.
  • 8Gridelli C, Perrone F, Gallo C, et al. Chemotherapy for elderly pa- tients with advanced nonsmall cell lung cancer. The multi-center Italian lung cancer in the elderly study ( MILES ) phase III ran- domized trial[ J]. J Natl Cancer Inst ,2003,95 (5) :362-372.
  • 9Lanser C J, Manola J, Bemardo P, et al. Cisp|atin-based therapy for elderly patients with advaned nonsmall cell lung cancer:Implica- tions of Eastern Cooperative Oneology Group 5592, A Randomized trial[J]. J Nail Cancer Inst,2002,94(3) :173-181.
  • 10Costa GJ, Fernandes AL, Pereira JR, et al. Survival rates and to- hrability of platinum-based chemotherapy resimens for elderly pa- tients with non-small-cell lung patients[ J]. Lung Cancer,2006, 53(2) :171-176.

引证文献7

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部